Tag:
Menactra
Latest Headlines
Latest Headlines
FDA approves Sanofi's Menactra as meningococcal booster
The new nod could boost sales of the French drugmaker's vaccine, a lift it could use after Menactra's top-line haul in 2013 sank to €424 million in a 21.5% slide.
Sanofi Pasteur nabs Menactra expansion in Canada
Health Canada gave the nod to Sanofi Pasteur Canada to expand the indication for Menactra to infants 9 months of age.
20 Top-selling Vaccines-- H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.
The 20 top-selling vaccines in H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>
Sanofi readies defense as judge rules antitrust lawsuit can proceed
Sanofi Pasteur may find itself in the thick of an antitrust case after a judge ruled that a lawsuit alleging that the company illegally monopolizes the market for meningococcal vaccines in the U.S. can move forward.
FDA clears Menactra for infants
The FDA has expanded the indication of Sanofi-Aventis' Menactra to include a two-dose schedule for infants and children 9 months through 23 months of age, marking the first time a meningococcal
Vax panel votes to add meningitis booster dose
The CDC's Advisory Committee on Immunization Practices voted 6-5 Wednesday to add a booster dose of the meningitis vaccine at age 16. Reuters notes that health officials want to address waning
